Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflammatory agent. I. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis.
AUTOR(ES)
Chalmers, T M
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1031292Documentos Relacionados
- Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis.
- Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.
- Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity.
- Serum cytidine deaminase levels after withdrawal of non-steroidal anti-inflammatory treatment in rheumatoid arthritis.
- Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.